We are live on ! Find out more
Commonwealth Equity Services

Commonwealth Equity Services Portfolio holdings

AUM $71.6B
1-Year Est. Return 21.08%
This Fund
S&P 500
This Quarter Est. Return
+3.1%
1 Year Est. Return
+21.08%
3 Year Est. Return
+64.42%
5 Year Est. Return
+73.55%
10 Year Est. Return
+239.11%
AUM
$63.2B
AUM Growth
+$2.99B
Cap. Flow
+$1.63B
Cap. Flow %
2.58%
Top 10 Hldgs %
20.27%
Holding
4,222
New
203
Increased
2,047
Reduced
1,654
Closed
188

Sector Composition

Rank Sector Weight
1 Technology 13.04%
2 Financials 5.25%
3 Consumer Discretionary 4%
4 Healthcare 3.99%
5 Industrials 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIFA
4026
All In FutureTech Alliance Inc
AIFA
$12.2M
-1,738
Closed -$11K
AGEN
4027
Agenus
AGEN
$249M
-756
Closed -$9K
AGYS icon
4028
Agilysys
AGYS
$2.78B
-6,936
Closed -$584K
ALGT icon
4029
Allegiant Air
ALGT
$2.64B
-3,496
Closed -$263K
ALV icon
4030
Autoliv
ALV
$8.6B
-2,244
Closed -$270K
AMR icon
4031
Alpha Metallurgical Resources
AMR
$1.82B
-973
Closed -$322K
ANGI icon
4032
Angi Inc
ANGI
$224M
-1,938
Closed -$51K
APLS
4033
DELISTED
Apellis Pharmaceuticals
APLS
-4,919
Closed -$289K
APPN icon
4034
Appian
APPN
$1.74B
-6,589
Closed -$263K
APUE icon
4035
ActivePassive US Equity ETF
APUE
$2.39B
-11,264
Closed -$364K
ARAY icon
4036
Accuray
ARAY
$28.4M
-13,000
Closed -$32K
CVSA
4037
Covista Inc
CVSA
$3.94B
-6,054
Closed -$311K
ATMU icon
4038
Atmus Filtration Technologies
ATMU
$4.37B
-8,002
Closed -$258K
ATRA icon
4039
Atara Biotherapeutics
ATRA
$71.2M
-678
Closed -$12K
AUPH icon
4040
Aurinia Pharmaceuticals
AUPH
$1.97B
-11,307
Closed -$57K
AVTR icon
4041
Avantor
AVTR
$7.81B
-10,742
Closed -$275K
AXS icon
4042
AXIS Capital
AXS
$8.59B
-10,294
Closed -$669K
BBAX icon
4043
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.56B
-4,289
Closed -$207K
BCDA icon
4044
BioCardia
BCDA
$12.7M
-2,000
Closed -$12K
BDSX icon
4045
Biodesix
BDSX
$228M
-816
Closed -$23K
BEAM icon
4046
Beam Therapeutics
BEAM
$2.58B
-11,864
Closed -$392K
BIO icon
4047
Bio-Rad Laboratories Class A
BIO
$8.42B
-2,114
Closed -$731K
BL icon
4048
BlackLine
BL
$1.69B
-4,127
Closed -$267K
BRBS icon
4049
Blue Ridge Bankshares
BRBS
$311M
-11,603
Closed -$31K
STEX
4050
Streamex Corp
STEX
$76.7M
-12,500
Closed -$8K

Similar funds

Commonwealth Equity Services's Q2 2024 Portfolio in Review

As of Q2 2024, Commonwealth Equity Services held 4,222 positions worth $63.2B, up 5% from $60.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Commonwealth Equity Services's Q2 2024 filing shows 203 new, 2,047 increased, 1,654 reduced and 188 closed positions. Its largest new stake was Innovator Nasdaq-100 Managed Floor ETF: 710,501 shares worth $19.5M. The largest sale was Schwab US Dividend Equity ETF, an estimated $36M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Commonwealth Equity Services's largest Q2 2024 buy was Innovator Nasdaq-100 Managed Floor ETF: 710,501 shares worth $19.5M.
  • Commonwealth Equity Services added most to Capital Group Dividend Value ETF in Q2 2024, an estimated $47.5M increase.
  • Commonwealth Equity Services's biggest Q2 2024 reduction was Schwab US Dividend Equity ETF, cutting an estimated $36M.
  • Commonwealth Equity Services fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $12.4M.
  • Commonwealth Equity Services's ten largest holdings make up 20% of its $63.2B portfolio in Q2 2024.
  • Commonwealth Equity Services opened 203 new positions and closed 188 in Q2 2024.
  • Commonwealth Equity Services's portfolio value rose 5% quarter-over-quarter to $63.2B.

Based on Commonwealth Equity Services's 13F filing for Q2 2024, filed 31 Jul 2024.